- Home
- NMI vs INCR Comparison
NMI vs INCR Comparison
Compare NMI & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMI
- INCR
- Stock Information
- Founded
- NMI 1988
- INCR 1994
- Country
- NMI United States
- INCR Israel
- Employees
- NMI N/A
- INCR N/A
- Industry
- NMI Trusts Except Educational Religious and Charitable
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- NMI Finance
- INCR Health Care
- Exchange
- NMI Nasdaq
- INCR Nasdaq
- Market Cap
- NMI 101.7M
- INCR 86.1M
- IPO Year
- NMI N/A
- INCR N/A
- Fundamental
- Price
- NMI $10.01
- INCR $1.48
- Analyst Decision
- NMI
- INCR
- Analyst Count
- NMI 0
- INCR 0
- Target Price
- NMI N/A
- INCR N/A
- AVG Volume (30 Days)
- NMI 28.4K
- INCR 134.4K
- Earning Date
- NMI 01-01-0001
- INCR 10-08-2025
- Dividend Yield
- NMI 4.10%
- INCR N/A
- EPS Growth
- NMI N/A
- INCR N/A
- EPS
- NMI N/A
- INCR N/A
- Revenue
- NMI N/A
- INCR $72,158,312.00
- Revenue This Year
- NMI N/A
- INCR $69.54
- Revenue Next Year
- NMI N/A
- INCR $41.75
- P/E Ratio
- NMI N/A
- INCR N/A
- Revenue Growth
- NMI N/A
- INCR N/A
- 52 Week Low
- NMI $8.30
- INCR $1.17
- 52 Week High
- NMI $10.05
- INCR $1.82
- Technical
- Relative Strength Index (RSI)
- NMI 59.61
- INCR 41.77
- Support Level
- NMI $10.00
- INCR $1.42
- Resistance Level
- NMI $10.11
- INCR $1.65
- Average True Range (ATR)
- NMI 0.06
- INCR 0.08
- MACD
- NMI -0.01
- INCR -0.02
- Stochastic Oscillator
- NMI 18.21
- INCR 23.08
About NMI Nuveen Municipal Income Fund Inc.
Nuveen Municipal Income Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.